Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harrigan

Showing results (871-880 of 1,264) with videos related to

Pageof 127
Sort By:
The Journal of Antimicrobial Chemotherapy|March 11, 2015
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological responseCharlotte Charpentier, Guinevere Q Lee, Christophe Rodriguez, et al.
Antiviral Therapy|May 15, 2002
Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British ColumbiaChristopher S Alexander, Valentina Montessori, Brian Wynhoven, et al.
The Journal of Infectious Diseases|August 5, 2003
Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced diseaseChristopher S Alexander, Jérôme J Asselin, Lillian S L Ting, et al.
Antiviral Therapy|December 3, 2003
Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapyP Richard Harrigan, Kurt Hertogs, Werner Verbiest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1David J H F Knapp, Zabrina L Brumme, Sheng Yuan Huang, et al.
AIDS (London, England)|August 12, 2011
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing dataArt F Y Poon, Rachel A McGovern, Theresa Mo, et al.
Breast Cancer Research and Treatment|August 1, 2018
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) studyTara Sanft, Ilana Usiskin, Maura Harrigan, et al.
Inflammatory Bowel Diseases|January 9, 2007
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximabBruce E Sands, Richard Kozarek, Jack Spainhour, et al.
Plos One|February 6, 2013
Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, CanadaBohdan Nosyk, Guillaume Colley, Benita Yip, et al.
Plos One|June 7, 2014
Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapyGuinevere Q Lee, Winnie Dong, Theresa Mo, et al.
Pageof 127

Showing results (871-880 of 1,264) with videos related to

Sort By:
Pageof 127
The Journal of Antimicrobial Chemotherapy|March 11, 2015
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological responseCharlotte Charpentier, Guinevere Q Lee, Christophe Rodriguez, et al.
Antiviral Therapy|May 15, 2002
Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British ColumbiaChristopher S Alexander, Valentina Montessori, Brian Wynhoven, et al.
The Journal of Infectious Diseases|August 5, 2003
Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced diseaseChristopher S Alexander, Jérôme J Asselin, Lillian S L Ting, et al.
Antiviral Therapy|December 3, 2003
Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapyP Richard Harrigan, Kurt Hertogs, Werner Verbiest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Increasingly successful highly active antiretroviral therapy delays the emergence of new HLA class I-associated escape mutations in HIV-1David J H F Knapp, Zabrina L Brumme, Sheng Yuan Huang, et al.
AIDS (London, England)|August 12, 2011
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing dataArt F Y Poon, Rachel A McGovern, Theresa Mo, et al.
Breast Cancer Research and Treatment|August 1, 2018
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) studyTara Sanft, Ilana Usiskin, Maura Harrigan, et al.
Inflammatory Bowel Diseases|January 9, 2007
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximabBruce E Sands, Richard Kozarek, Jack Spainhour, et al.
Plos One|February 6, 2013
Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, CanadaBohdan Nosyk, Guillaume Colley, Benita Yip, et al.
Plos One|June 7, 2014
Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapyGuinevere Q Lee, Winnie Dong, Theresa Mo, et al.
Pageof 127